Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28,903,706
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
5,108,808
-
Shares change
-
+236,329
-
Total reported value, excl. options
-
$175,588,000
-
Value change
-
+$15,879,309
-
Number of buys
-
47
-
Number of sells
-
-20
-
Price
-
$34.37
Significant Holders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) as of Q4 2019
74 filings reported holding CSTL - CASTLE BIOSCIENCES INC - Common Stock as of Q4 2019.
CASTLE BIOSCIENCES INC - Common Stock (CSTL) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5,108,808 shares
of 28,903,706 outstanding shares and own 18% of the company stock.
Largest 10 shareholders include HIGHLAND CAPITAL MANAGEMENT FUND ADVISORS, L.P. (707,032 shares), RTW INVESTMENTS, LP (631,072 shares), BlackRock Inc. (435,174 shares), WASATCH ADVISORS INC (376,367 shares), DRIEHAUS CAPITAL MANAGEMENT LLC (365,632 shares), Portolan Capital Management, LLC (305,578 shares), GOLDMAN SACHS GROUP INC (304,189 shares), ARK Investment Management LLC (206,014 shares), VANGUARD GROUP INC (200,502 shares), and LORD, ABBETT & CO. LLC (178,196 shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.